High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: A South American health concern

AIDS Research and Human Retroviruses

Volumn 21, Issue 1, 2005, Pages 1-4

  Biglione, Mirna M ^a   Astarloa, Laura ^b   Salomón, Horacio E ^a   Fabre, Adriana R ^c   Fernandez Carrillo R ^d   Iriarte, Elida ^e   Muzzino, Silvana ^f   Gonzalez, María De Los Ángeles Nieves ^f   Abdala, Haydee S ^g   Brun, Rogue O ^h   Chaki, Susana ⁱ   Magrans, Stella ^j   Sciulli, Maria ^k  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Min de Salud y Accion Social   (Argentina)

^c Hospital Julio C Perrando   (Argentina)

^d Banco de Sangre Central   (Argentina)

^e Sanatorio Adventista del Plata   (Argentina)

^f Lab Referencia Enferm T   (Argentina)

^g Hospital San Bernardo   (Argentina)

^h Laboratorio Central   (Argentina)

ⁱ Hospital Horacio Heller   (Argentina)

^j Hospital Zonal de Trelew   (Argentina)

^k Programa Provincial de SIDA/ETS   (Argentina)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGENTINA; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ENDEMIC DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SEROPREVALENCE; VIRUS INFECTION;

ADULT; ARGENTINA; BLOOD DONORS; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 19944431231     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.1     Document Type: Article

References (24)

1. Uchiyama T, Yodoi J, Sagawa K, et al.: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1997;50:481-492.
2. Gessain A, Barin F, Vemant JC, et al.: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410.
3. Manns A, Hisada M, and La Grenade L: Human T-lymphotropic virus type I infection. Lancet 1999;353:1951-1958.
4. Kaplan JE and Khabbaz RF: The epidemiology of human T-lymphotropic virus types I and II. Med Virol 1993;3:137-148.
5. Hjelle B, Appenzeller O, and Mills R: Chronic neuro-degenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
6. Levine PH and Blattner WA: The epidemiology of diseases associated with HTLV-I and HTLV-II. Infect Dis Clin North Am 1987;1:501-510.
7. Blattner WA: Human T-lymphotrophic viruses and diseases of long latency. Ann Intern Med 1989;1:4-6.
8. Okochi K and Sato H: Transmission of adult T-cell leukemia virus (HTLV-1) through blood transfusion and its prevention. AIDS Res 1986;2:157-161.
9. Manns A and Blattner WA: The epidemiology of the human T-cell lymphotropic virus type I and II: Etiologic role in human disease. Transfusion 1991;31:67-75.
10. Gessain A and Gout O: Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992;117:933-946.
11. Libonatti O, Lombardi V, and Boxaca M: Prevalencia de anticuerpos anti-HTLV-I en adictos a drogas endovenosas en la Argentina. Medicina (B Aires) 1989;49:546-547.
12. Ferrer JF, Esteban E, Dube S, et al.: Endemic infection with human T cell leukemia/lymphoma virus type IIB in Argentinean and Paraguayan Indians: Epidemiology and molecular characterization. J Infect Dis 1996;174:944-953.
13. Biglione M, Gessain A, Quiruelas S, et al.: Endemic HTLV-II infection among Toba and Mataco Amerindians from north Argentina. J Acquir Immune Defic Syndr 1993;6:631-633.
14. Dipierri JE, Tajima K, Cartier Robirosa L, and Sonoda S: A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña. Medicina (B Aires) 1999;59:717-720.
15. Biglione M, Pizarro M, Martínez Peralta L, Libonatti O, and Avila M: High prevalence of HTLV-I infection in Argentinian blood donors. A new HTLV-I endemic area? J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:101-102.
16. Del Pino N, Martínez Peralta L, Pampuro S, et al.: HTLV-I/II seroprevalence and coinfection with other pathogens in blood donors in Buenos Aires. J Acquir Immune Defic Syndr 1994;7:206-207.
17. Gutfraind Z, Blejer J, Saguier MC, et al.: Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires (Argentina). Vox Sang 1994;67:408-409.
18. Marin O, Hasui K, Remondegui C, et al.: Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina. Pathol Int 2002;52:348-357.
19. Biglione M, Pizarro M, Puca A, Salomón HE, and Berría MI: A cluster of human T-cell lymphotropic virus type i-associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina. J Acquir Immune Defic Syndr 2003;32:441-445.
20. Bouzas MB, Zapiola I, Quiruelas S, et al.: HTLV type I and HTLV type II infection among Indians and natives from Argentina. AIDS Res Hum Retroviruses 1994;10:1567-1571.
21. Censabella M: La Familia Tupi-Guaraní. In: Las lenguas indígenas de la Argentina. Universitaria de Buenos Aires, Sociedad de Economía Mixta, Buenos Aires, 1999, pp. 47-60.
22. Fujiyoshi T, Li HC, Yashiki S, et al.: Characteristic distribution of HTLV type I and HTLV type II among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999;15:1235-1239.
23. Cartier Rovirosa L, Mora C, Araya F, et al.: HTLV-I positive spastic paraparesis in a temperate zone. Lancet 1989;1:556-557.
24. Remesar M, Mangano A, Sen L, and del Pozo A: Profile of human T-cell lymphotopic virus-I/II infections in an Argentinean blood bank population. Vox Sang 2002;83:364-365.